This mechanism suggests that EZH2 inhibitors may restore the expression of tumor suppressor genes such as E-cadherin by blocking the formation of the HOTAIR-PRC2 complex, thereby inhibiting tumor invasion and metastasis. Here, EZH2 is linked to neoplasm.